Advertisement

Insulin pumps could be hacked warns Johnson & Johnson

Diabetics warned over digital insulin pumps being hacked
Johnson & Johnson is warning users of a cyber security bug in one of its insulin pumps that could allow a hacker to overdose diabetic patients, Reuters has learned. Fred Katayama reports.

(Reuters) – Johnson & Johnson is telling patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin, though it describes the risk as low.

Medical device experts said they believe it was the first time a manufacturer had issued such a warning to patients about a cyber vulnerability, a hot topic in the industry following revelations last month about possible bugs in pacemakers and defibrillators.

READ MORE: First ‘artificial pancreas’ approved in U.S. for diabetes: When will Canadians get it?

Johnson & Johnson executives told Reuters they knew of no examples of attempted hacking attacks on the device, the Johnson & Johnson Animas OneTouch Ping insulin pump. The company is nonetheless warning customers and providing advice on how to fix the problem.

“The probability of unauthorized access to the OneTouch Ping system is extremely low,” the company said in letters sent on Monday to doctors and about 114,000 patients who use the device in the United States and Canada.

Story continues below advertisement

“It would require technical expertise, sophisticated equipment and proximity to the pump, as the OneTouch Ping system is not connected to the internet or to any external network.”

Tweet This

A copy of the text of the letter was made available to Reuters.

Insulin pumps are medical devices that patients attach to their bodies that injects insulin through catheters.

The Animas OneTouch Ping, which was launched in 2008, is sold with a wireless remote control that patients can use to order the pump to dose insulin so that they do not need access to the device itself, which is typically worn under clothing and can be awkward to reach.

WATCH: What’s it like to live with Type 1 diabetes?

What’s it like to live with Type 1 diabetes?
What’s it like to live with Type 1 diabetes?

Jay Radcliffe, a diabetic and researcher with cyber security firm Rapid7 Inc, said he had identified ways for a hacker to spoof communications between the remote control and the OneTouch Ping insulin pump, potentially forcing it to deliver unauthorized insulin injections.

The system is vulnerable because those communications are not encrypted, or scrambled, to prevent hackers from gaining access to the device, said Radcliffe, who reported vulnerabilities in the pump to Johnson & Johnson in April and published them on the Rapid7 blog on Tuesday.

Story continues below advertisement

Johnson & Johnson executives said they worked on the security issues with Radcliffe.

Dosing a patient with too much insulin could cause hypoglycemia, or low blood sugar, which in extreme cases can be life threatening, said Brian Levy, chief medical officer with Johnson & Johnson’s diabetes unit.

Company technicians were able to replicate Radcliffe’s findings, confirming that a hacker could order the pump to dose insulin from a distance of up to 25 feet, Levy said. He said such attacks are difficult to pull off because they require specialized technical expertise and sophisticated equipment.

“We believe the OneTouch Ping system is safe and reliable. We urge patients to stay on the product,” Levy said.

Tweet This

Johnson & Johnson’s letter said that if patients were concerned, they could take several steps to thwart potential attacks. They include discontinuing use of a wireless remote control and programming the pump to limit the maximum insulin dose.

Radcliffe said he believed that OneTouch Ping users would be safe if they followed the steps outlined in the letters from Johnson & Johnson.

“They can give peace of mind to the patient or parent of a child using the device,” he said.

Johnson & Johnson Chief Information Security Officer Marene Allison said her team would make sure other J&J products do not have similar bugs.

Story continues below advertisement

READ MORE: Kelowna man fighting type 1 diabetes takes on Ironman

Radcliffe said he found vulnerabilities in the Animas OneTouch Ping, but not the Animas Vibe line of insulin pumps.

Suzanne Schwartz, an FDA official responsible for reviewing bugs in medical devices, said in a statement that she encourages collaboration between researchers and device manufacturers to identify, remediate and alert the public to vulnerabilities.

“It enables all stakeholders to better address device safety with the interest of patient health in mind,” she said.

The FDA has said it knows of no cases where hackers have exploited cyber vulnerabilities to harm a patient.

The agency last year issued multiple warnings about cyber bugs in infusion pumps from Hospira, which has since been acquired by Pfizer Inc.